UCLA research could lead to a simple saliva test capable of diagnosing — at an early stage — diabetes and cancer, and perhaps neurological disorders and autoimmune diseases.
The study, the most comprehensive analysis ever conducted of RNA molecules in human saliva, reveals that saliva contains many of the same disease-revealing molecules that are contained in blood. It was published online today by the peer-reviewed journal Clinical Chemistry and will be published in the journal’s January 2015 special print issue, “Molecular Diagnostics: A Revolution in Progress.”
“If we can define the boundaries of molecular targets in saliva, then we can ask what the constituents in saliva are that can mark someone who has pre-diabetes or the early stages of oral cancer or pancreatic cancer — and we can utilize this knowledge for personalized medicine,” said Dr. David Wong, a senior author of the research and UCLA’s Felix and Mildred Yip Endowed Professor in Dentistry.
Wong said the test also holds promise for diagnosing Type 2 diabetes, gastric cancer and other diseases. “If you don’t look in saliva, you may miss important indicators of disease,” Wong said. “There seems to be treasure in saliva, which will surprise people.”
RNA, widely known as a cellular messenger that makes proteins and carries out DNA’s instructions to other parts of the cell, is now understood to perform sophisticated chemical reactions and is believed to perform an extraordinary number of other functions, at least some of which are unknown.
Wong’s research over the past decade has focused on identifying biomarkers in saliva. His laboratory discovered that some of the same RNA that is inside human cells are also present in saliva and can be used to detect diseases — a surprising finding, he said, because enzymes in saliva can degrade RNA, making the mouth “a hostile environment.”
The new research is a collaboration with Xinshu (Grace) Xiao, the paper’s other senior author and a UCLA associate professor of integrative biology and physiology in the UCLA College. Using state-of-the-science genomics and bioinformatics, the researchers analyzed 165 million genetic sequences.
Among the many forms of RNA are some unusual ones that live in the mouth and in cells. For example, it wasn’t known until very recently that RNA comes in a circular form; the linear form has long been known. But the UCLA scientists identified more than 400 circular RNAs in human saliva — the first discovery of circular RNA in saliva or any body fluid — including 327 forms that were previously unknown.
Circular RNA’s function in saliva is not entirely understood, although it does serve as a sponge for tiny RNA molecules called microRNAs, which bind to it.
“Circular RNAs in saliva may be protecting other RNAs,” said Xiao, who also is a member of UCLA’s Molecular Biology Institute. It’s likely, she said, that circular RNAs in saliva protect microRNAs from being degraded.
MicroRNAs, which once seemed to be little more than molecular noise, play important roles in many cell types, and have been implicated in cancers and other diseases, Xiao said. One microRNA can regulate hundreds of genes, she said.
The scientists compared microRNA levels in saliva to those in the blood and other body fluids, and found the levels of microRNA in blood and in saliva are very similar — indicating that a saliva sample would be a good measure of microRNAs in the body.
They also found that saliva contains another class of small RNAs, called piwi-interacting RNAs, or piRNAs, which are produced by stem cells, skin cells and germ cells. There are very few piRNAs in blood and most other body fluids, but Xiao’s analysis showed that piRNA are abundant in saliva. Although their function is not yet known, Xiao said they may protect the body from viral infection.
While most RNA molecules translate genetic code from DNA to make proteins, there is also a class called non-coding RNAs that does not.
“Saliva carries with it non-coding RNAs, microRNAs, piRNAs and circRNAs that are biomarkers for disease and health monitoring,” said Wong, who also is associate dean of research at the UCLA School of Dentistry. “Had we not done this collaboration, we would never know that non-coding RNAs, microRNAs, piRNAs and circRNAs exist in saliva.”
Their overriding conclusion is that saliva has tremendous medical and scientific value. In the not-too-distant future, dentists might be able to take saliva samples to analyze for a variety of diseases. And, Wong says, the research could lead to a new category of self-diagnostic devices. “This could indicate that wearable gear that informs you whether you have a disease — even before you have any symptoms — is almost here,” he said.
The Latest on: Molecular diagnostics
via Google News
The Latest on: Molecular diagnostics
- New MRI technique can 'see' molecular changes in brainon September 6, 2019 at 8:05 am
Scientists have successfully transformed an MRI from a diagnostic camera into a device that can record ... "Instead of images, our quantitative MRI model provides molecular information about the brain ...
- Gaithersburg’s OpGen to combine with German molecular diagnostic companyon September 5, 2019 at 12:58 pm
Local biotech OpGen Inc. has reached a deal to join forces with a German molecular diagnostic company, creating a combined business worth about $24 million. The Gaithersburg-based precision medicine ...
- OpGen To Merge With German Molecular Diagnostics Company Curetis In $24M Dealon September 4, 2019 at 12:17 pm
In a health care deal announced Wednesday, OpGen Inc (NASDAQ: OPGN) said it will acquire German molecular diagnostics company Curetis. The Deal Terms OpGen, a precision medicine company that uses ...
- Molecular Diagnostics Market 2019 - 2024 Trends, Analysis, Market Forecaston September 4, 2019 at 8:05 am
Sep 04, 2019 (Heraldkeepers) -- New York, September 04, 2019: Molecular diagnostics is a way of performing a diagnostic test to discover ailment, circumstance or infection in an artificial ...
- Asia-Pacific In-Vitro Diagnostics Market is Expected to Reach $19.0 Billionon September 4, 2019 at 6:18 am
The growing trend of diagnostic tools such as, clinical chemistry and molecular diagnostic would largely drive the market growth during the forecast period. However, blood testing is projected to be ...
- Co-Diagnostics, Inc. and LGC, Biosearch Technologies Expand License Agreement for CoPrimer™ Technologyon September 4, 2019 at 3:30 am
(“Co-Diagnostics,” or the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, and LGC, Biosearch Technologies ...
- Molecular Diagnostics Picks Up the Paceon September 3, 2019 at 4:32 am
Two decades ago, the thinking was that diagnostics would be largely conducted at the molecular level. It was anticipated that technologies capable of identifying a pathogen or a gene with high ...
- At 9.5% CAGR, Companion Animal Diagnostic Market Size Raising to USD 3.18 billion by 2026on September 3, 2019 at 4:25 am
On the basis of technology segment, the market is sub-segmented into clinical biochemistry, immunodiagnostics, hematology, urinalysis, molecular diagnostics and other companion animal diagnostic ...
- Co-Diagnostics CEO Opens up on Goals and Milestones in Interview with Wall Street Analyzeron August 29, 2019 at 4:00 am
New York City, New York, Aug. 29, 2019 (GLOBE NEWSWIRE) -- The Wall Street Analyzer recently completed and published an interview with the CEO of Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular ...
- Molecular Diagnostics Market 2019-2028: Technologies and Companieson August 27, 2019 at 10:43 am
This report describes and evaluates the molecular diagnostics technologies that will play an important role in practice of medicine, public health, pharmaceutical industry, forensics and biological ...
via Bing News